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Abstract
For the outcomes and phenotypes of complex diseases, multiple types of molecular (genetic,
genomic, epigenetic, etc.) changes, environmental risk factors, and their interactions have been
found to have important contributions. In each of the existing studies, only the interactions
between one type of molecular changes and environmental risk factors have been analyzed.
In recent biomedical studies, multidimensional profiling, under which data on multiple types
of molecular changes is collected on the same subjects, is becoming popular. A myriad of
recent studies have shown that collectively analyzing multiple types of molecular changes is
not only biologically sensible but also leads to improved estimation and prediction. In this
study, we conduct M-E interaction analysis, with M standing for multidimensional molecular
changes and E standing for environmental risk factors, which can accommodate multiple types of
molecular measurements and sufficiently account for their overlapping information (attributable
to regulations) as well as independent information. The proposed approach is based on the
penalization technique, has a solid statistical ground, and can be effectively realized. Extensive
simulation shows that it outperforms multiple closely relevant alternatives. In the analysis of
TCGA (The Cancer Genome Atlas) data on lung adenocarcinoma and cutaneous melanoma,
sensible findings with superior stability and prediction are made.
Keywords: Interaction analysis, multidimensional molecular data, environmental risk factors,
high-dimensional estimation
1 Introduction
For the outcomes and phenotypes of cancer, cardiovascular diseases, asthma, mental disorders,
and other complex diseases, accumulating evidences have shown that multiple types of molecular
∗To whom correspondence should be addressed.
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changes, environmental risk factors, and their interactions play important roles. For example, the
expression of gene IL9 is found to interact with environmental dust mite to increase severe asthma
exacerbations in children (Sordillo et al., 2015). In the study of lung cancer genetics, it has been
suggested that smoking can act through increasing the CNV (copy number variation) of gene IGF1
to induce its oncogenesis (Huang et al., 2011). Epigenetic changes have also been investigated.
For example, Teschendorff et al. (2015) finds that smoking-associated DNA methylation changes in
buccal cells are associated with epithelial cancers. It is observed that in each of the aforementioned
and other published studies, only the interactions between a single type of molecular changes and
environmental risk factors have been analyzed.
In recent biomedical studies, multidimensional profiling is becoming popular. In such studies,
data on multiple types of molecular changes is collected on the same subjects. Such studies make
it possible to not only more deeply understand disease biology but also construct more effective
models for disease outcomes and phenotypes. A myriad of novel statistical methods have been
developed. For example, Wang et al. (2012) proposes an integrative Bayesian analysis to identify
gene expression and methylation measurements that are associated with clinical outcomes such as
survival. Gross and Tibshirani (2014) develops collaborative regression which applies penalization
to explicitly accommodate the correlations (overlapping information) as well as independent infor-
mation between gene expressions and CNVs for marker identification. Zhu et al. (2016) develops a
linear regulatory module-based method using the sparse SVD (singular value decomposition) and
penalization techniques to integrate gene expressions and their regulators for cancer outcomes. We
refer to Kristensen et al. (2014) and Wu et al. (2019a) for more discussions. The aforementioned
and other published studies have convincingly shown that integrating multidimensional molecu-
lar data not only is biologically sensible but also improves estimation, marker identification, and
prediction. It is noted that these studies have focused on the main effects of molecular changes.
Motivated by the successes as well as limitations of the existing studies, here we conduct M-
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E interaction analysis, where M stands for multidimensional molecular changes and E stands for
environmental risk factors. The objective is to collectively accommodate multiple types of high-
dimensional molecular changes, environmental risk factors, and their interactions in modeling dis-
ease outcomes and phenotypes. This analysis is the natural next step of the integrated analysis of
the main effects of multidimensional molecular data and studies that conduct the interaction anal-
ysis of a single type of molecular changes and environmental risk factors. Beyond the “ordinary”
high dimensionality and noisy nature of molecular data, the analysis faces other challenges. Specif-
ically, multiple types of molecular measurements are interconnected, which leads to overlapping
information. For example, gene expression levels are regulated by genetic and epigenetic changes.
On the other hand, they can also have independent information for disease outcomes (Risch and
Plass, 2008). Several techniques, for example built on canonical correlation analysis (Meng et al.,
2016) and matrix factorization (Zhang and Zhang, 2019), have been developed to accommodate
such overlapping and independent information. In addition, interaction analysis demands respect-
ing the unique “main effects, interactions” hierarchy (Bien et al., 2013; Wu et al., 2019b), for which
multiple regularization techniques have been developed.
This study has the potential to significantly expand the gene-environment interaction analysis
and multidimensional molecular data analysis paradigms. The proposed approach is designed
tailored to the M-E analysis and will significantly advance from the aforementioned ones. With the
growing popularity of multidimensional profiling, this study can open a new venue for modeling
complex diseases.
2 Methods
The proposed approach can accommodate multiples types/combinations of molecular measure-
ments. Without loss of generality and to avoid confusion with terminologies, we use gene expressions
and their regulators (for example, genetic and epigenetic changes) as an example in description.
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Such a combination has been quite popular in published studies (Wang et al., 2012; Zhu et al., 2016).
Other combinations, for example proteins and gene expressions, can be analyzed in the same man-
ner. Assume n iid subjects. Denote G = (G1, · · · ,Gp) andR = (R1, · · · ,Rq) as the n×p and n×q
design matrices of p gene expression and q regulator measurements. Denote E = (E1, · · · ,EM ) as
the n×M design matrix of environmental risk factors, and Y as the length n vector of outcome.
We first consider continuous outcomes and will discuss accommodating other types of outcomes
later. Assume Y has been properly centered, and E,X, and Z have been standardized.
2.1 M-E interaction analysis
Our goal is to identify important M-E interactions (as well as main effects) and construct a com-
prehensive outcome model. Overall, the proposed approach consists of the following main steps: (i)
identification of the gene expression-regulator regulatory modules, which describe the regulation re-
lationships (overlapping information), (ii) integration of multidimensional molecular measurements
within the regulatory modules, and (iii) joint modeling and estimation that respect the “main
effects, interactions” hierarchy. The analysis flowchart is provided in Figure A1 (Appendix).
Step I We employ a penalized regression to estimate the gene expression-regulator regulations
and then sequentially conduct biclustering to identify the regulatory modules. Consider the model
G = RΘ + , where  is the n × p matrix of random errors and Θ = (θ1, · · · ,θp) is the q × p
unknown coefficient matrix. For estimating Θ, consider
Θˆ = arg min
Θ
1
2
||G−RΘ||2F + λ
p∑
j=1
||θj ||1, (1)
where || · ||F and || · ||1 denote the Frobenius norm of a matrix and L1 norm of a vector, and λ ≥ 0
is the tuning parameter.
To identify the regulatory modules, we propose conducting biclustering with Θˆ. Here a reg-
ulatory module corresponds to a bicluster, which contains a small number of co-expressed gene
expressions and their regulators. Specifically, for estimation, we adopt the sparse clustering tech-
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nique developed in Helgeson et al. (2019), which first introduces weights for gene expressions and
then maximizes the weighted between-cluster distance for regulators. The objective function is
max
C,C¯,w
p∑
j=1
wj
1
q
q∑
l=1
q∑
l′=1
dl,l′,j − 1
q1
∑
l,l′∈C
dl,l′,j − 1
q2
∑
l,l′∈C¯
dl,l′,j
 , (2)
subject to ||w||2 ≤ 1, ||w||1 ≤ √p, and wj ≥ 0 for j = 1, · · · , p,
where θˆlj is the (l, j)th component of Θˆ, dl,l′,j =
(
θˆlj − θˆl′j
)2
measures the distance between the
lth and l′th regulators, C and C¯ are the disjoint index sets of regulator clusters, q1 = |C| and q2 = |C¯|
are the cardinalities of C and C¯ with q1 < q2 and q1 + q2 = q, and w = (w1, · · · , wp)′ is the weight
vector for gene expressions, with a larger weight indicating higher importance for clustering. With
the constraints for w, each wj has a nonzero value between 0 and 1. With the estimated weight wˆ, a
two-sample permutation-based Kolmogorov-Smirnov test is conducted to test the significance of the
difference between two clusters and select the gene expression set D with significantly large weights.
This process leads to one regulatory module {C,D} with regulators in C and gene expressions in
D. To obtain subsequent modules, we update Θˆ by subtracting the module just identified and
repeat the above procedure. This process is iterated until the Kolmogorov-Smirnov test fails to
reject the null hypothesis of no clusters. With the sparsity of Θˆ, it is expected that only a subset
of gene expressions and regulators can form modules. Suppose that there are S identified modules
{C1,D1} , · · · , {CS ,DS}.
Rationale Linear regression is used to describe the regulations between two types of molecular
measurements. Multiple published studies (Shi et al., 2015; Zhu et al., 2016) have shown that it is
a sensible choice, especially considering the high dimensionality. One gene expression is regulated
by only a few regulators, and one regulator affects the expressions of only a few genes. As such, Θ
is assumed to be sparse, and the Lasso penalization is applied for estimation and identification of
important regulations.
The concept of regulatory module has been developed in Zhu et al. (2016) and other studies.
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A regulatory module consists of a small number of gene expressions and regulators that behave
in a coordinated manner. The construction in Zhu et al. (2016), which is based on sparse SVD,
limits each regulatory module to have rank one. Here we lift this inconvenient constraint via
biclustering. By construction, each bicluster (regulatory module) consists of gene expressions and
regulators sharing similar patterns in Θ. We adopt the sparse biclustering method developed in
Helgeson et al. (2019) because of its favorable numerical performance. Note that here we cluster
regulators into two disjoint groups with weighted gene expressions. It is also possible to reverse
the roles of gene expressions and regulators, and this leads to similar clustering results in our
numerical investigations. With the sequential cluster construction strategy, different regulatory
modules may have overlaps. This is desirable as one gene/regulator can participate in multiple
biological processes.
Step II We integrates information within each regulatory module {Cs,Ds} , s = 1, · · · , S, using
the PCA (principle component analysis) technique. Given a matrix A and index set I, denote
AI as the columns of A indexed by I. For the sth module, we apply PCA to the stacked matrix
(GDs ,RCs) and select the top PCs with the cumulative variance contribution rate ≥ 80%. Denote
the resulted matrix composed of the ps PCs as Xs = (Xs,1, · · · ,Xs,ps). In addition, for gene
expressions and regulators not involved in any identified modules, we collect and combine them
as Z = (Z1, · · · ,Zpz) = (GDc ,RCc), where Dc = {j ∈ {1, · · · , p} : j /∈ Ds, s = 1, · · · , S} and
Cc = {j ∈ {1, · · · , q} : j /∈ Cs, s = 1, · · · , S}. X = (X1, · · · ,XS) and Z form input for downstream
analysis.
Rationale The previous step of analysis does not directly limit the sizes of the modules. Thus, it is
possible some modules have moderate to large sizes. In addition, with regulations, measurements
within the same modules often times have strong correlations. To reduce dimensionality, remove
collinearity, and simplify computation, we apply PCA, which can be replaced by other dimension
reduction techniques. Overall, the input for the next step consists of the PCs (representing overlap-
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ping information) and the gene expressions and regulators that do not form patterns (representing
independent information).
Step III Here we conduct interaction analysis, that respects the “main effects, interactions” hier-
archy (Bien et al., 2013). For the continuous outcome, consider the regression model
Y = Eα+
S∑
s=1
Xsβs +Zγ +
M∑
m=1
S∑
s=1
(E′m X ′s)′(βs ∗ ηsm) +
M∑
m=1
(E′m Z ′)(γ ∗ τm) + ξ,
= g(X,Z,E) + ξ. (3)
Here α = (α1, · · · , αM )′, β = (β′1, · · · ,β′S), and γ = (γ1, · · · , γpz)′ correspond to the main effects
of the environmental factors, regulatory modules, and individual molecular measurements (that
do note belong to any module), respectively. For the mth environmental factor, βs ∗ ηsm and
γ ∗ τm correspond to the interactions with the sth regulatory module and all individual molecular
measurements, respectively, with ∗ being the component-wise product.  is the “matching column-
wise” Khatri-Rao product. ξ is the random error vector. Here, following the literature (Choi et al.,
2010), we use the products EimXij and EimZij to describe the interactions for the ith subject. To
accommodate the hierarchical structure of interaction analysis, the interaction effects βsjηsmj and
γjτmj are decomposed into two components, the first for the corresponding main effects (βsj and
γj) and the other for the interaction-specific effects (ηsmj and τmj).
For the estimation and identification of important interactions (and main effects), we propose
the penalized objective function
Q(Φ) =
1
2
||Y − g(X,Z,E)||22
+ λ1
S∑
s=1
√
ps
(
||βs||2 +
M∑
m=1
||ηsm||2
)
+ λ2
(
||γ||1 +
M∑
m=1
||τm||1
)
, (4)
where Φ = (α′,β′1, · · · ,β′S ,γ ′,η′11, · · · ,η′MS , τ ′1, · · · , τ ′M )′, || · ||2 is the L2 norm of a vector, and
λ1, λ2 ≥ 0 are tuning parameters. Gene expressions and regulators that are involved in mod-
ules with nonzero estimated βs and βs ∗ ηsm are identified as having important main effects and
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M-E interactions, respectively. In addition, for individual molecular measurements, the nonzero
components of γ and γ ∗ τm correspond to important main effects and interactions, respectively.
Rationale A joint model is developed to accommodate all molecular and environmental effects and
their interactions. As to be described below, the linear regression model can be replaced by other
models. For estimation and selection, we adopt penalization, which has been the choice of quite a
few recent interaction studies (Bien et al., 2013; Wu et al., 2019b). For many datasets including
those analyzed in this article, the environmental factors are pre-selected based on existing knowledge
and usually considered as important, so that their coefficients are not subject to penalized selection.
As such, the “main effects, interactions” hierarchy postulates that an identified interaction corre-
sponds to an identified main molecular effect. To achieve this, we decompose the interaction effects
into two components and have that βsjηsmj 6= 0 only if βsj 6= 0 and γjτmj 6= 0 only if γj 6= 0 (Choi
et al., 2010). In (4), we employ group Lasso for regulatory modules (where PCs corresponding
to the same module form a group) and Lasso for individual molecular measurements to identify
M-E interactions and main effects. Here, all PCs corresponding to the same module are in or out
simultaneously, which is motivated by the coordinated nature of the molecular measurements in
the same module.
Accommodating other types of outcomes With a different type of outcome variable, the lack-
of-fit in (4) can be replaced by the negative log-likelihood function or an estimating equation-based
measure. As an example, consider survival data, which is analyzed below. Denote T as the length n
vector of survival times. Consider the AFT (accelerate failure time) model log(T ) = g(X,Z,E)+ξ,
where notations have similar implications as above. Denote C as the length n vector of censoring
times, then we observe Y = log(min(T ,C)) and δ = I(T ≤ C) with I(·) being the indicator
function. Assume that data has been sorted according to the observed times from the smallest to
the largest. Compute the Kaplan-Meier weights: ρ1 =
δ1
n , ρi =
δi
n−i+1
i−1∏
i′=1
( n−i
′
n−i′+1)
δi′ , i = 2, . . . , n.
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Then, we have the weighted penalized objective function
1
2
||√ρ ∗ (Y − g(X,Z,E))||22 + λ1
S∑
s=1
√
ps
(
||βs||2 +
M∑
m=1
||ηsm||2
)
+ λ2
(
||γ||1 +
M∑
m=1
||τm||1
)
.
2.2 Computation
The detailed computational algorithms for Steps I and III are provided in Algorithms 1 and 2 (Ap-
pendix), respectively. Step II can be realized using existing algorithms and R function prcomp. In
computation, effort has been made to take advantage of the existing algorithms and software. When
not possible, optimization has been based on the CD (coordinate descent) techniques. In the liter-
ature, convergence properties of the CD and other techniques used in computation have been well
established. Convergence is observed in all of our numerical studies. The two tuning parameters in
(4) are selected using the extended Bayesian information criterion (Chen and Chen, 2008). The pro-
posed algorithm is computationally feasible. For example, under a standard laptop configuration, it
takes less than five minutes for a simulated dataset with 250 subjects, 500 gene expression measure-
ments, and 500 regulator measurements. We have developed R code implementing the proposed ap-
proach and made it publicly available at https://github.com/shuanggema/omics_interaction.
2.3 Heuristic theoretical justifications
Consider the scenario where the number of molecular factors (gene expressions and their regulators)
increases and the number of environmental factors is finite as the sample size increases. There
are several key estimation procedures and conditions. First, in the step of identifying regulatory
modules, the consistency of Lasso estimator Θˆ is needed. For each gene expression, with probability
at least 1− 2√
pi
qu−1n e−u
2
n/2, θj can satisfy the weak oracle property, under mild regularity conditions
on the design matrix R, signal strengths, Gaussian random error, and q = o(une
u2n/2). Here, the
order of un can be o(n
a) with a ∈ (0, 12 ], leading to log(q) = o(n2a). Thus, with a total of p gene
expressions, to ensure the overall consistency of Θˆ, it is required that 1 − 2√
pi
qpu−1n e−u
2
n/2 → 1
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with the Bonferroni approach. Assume that p and q are of the same order, then we have log(q) =
log(p) = o(na). Second, the adopted biclustering strategy is an “upgrade” of the sparse K-means
clustering with an L2/L1 penalty. For the sparse K-means with an L∞/L0 penalty, it has been
shown in Chang et al. (2014) that under certain regularity conditions, the estimated weight w
has feature selection consistency. Consistency under an L2/L1 penalty is expected to hold with
revised norm assumptions, which will lead to consistency of the estimated gene expression clusters.
Consistency of the estimated cluster centres of K-means has been well established in Pollard et al.
(1981), which can support the consistency of the estimated regulator clusters. Combining such
results is expected to lead to the consistency of biclustering. Third, for each regulatory module,
PCA is conducted to extract integrated information. With the ratio n/(|Cs| + |Ds|) → 0, Jung
et al. (2009) shows that if the first few eigenvalues are large enough compared to the others, then
the corresponding estimated PC directions are consistent or converge to the appropriate subspace
(subspace consistency). Finally, for estimators in interaction analysis with hierarchy, consistency
has been established in Choi et al. (2010) and Wu et al. (2019b). As shown in Wu et al. (2019b),
under mild regularity conditions on the design matrix, smallest signal, and tuning parameters,
the estimator has consistency properties, where the dimensionality p + q is allowed to grow up
exponentially faster than the sample size.
3 Simulation
We set p = q = 500, M = 5, and n = 250, and generate environmental factors from independent
standard normal distributions. In addition, (a) we consider two settings for Θ to represent different
regulation patterns. The first (Θ1) contains 15 regulatory modules with one overlapping. The
corresponding elements are independently generated from normal distributions with mean ranging
from −0.7 to 1.5 and standard deviation 0.1, covering different levels and directions of regulations
on average. Each regulatory module contains 12.3 gene expressions and 16.6 regulators. The
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rest elements of Θ1 are zero. The second (Θ2) contains 20 nonzero regulatory modules with one
overlapping, and the nonzero values are generated similarly as Θ1. Those modules consist of 6.0
gene expressions and 8.1 regulators on average. Compared to Θ1, Θ2 contains more modules with
smaller sizes, representing a different type of regulations. (b) The values of regulators R involved in
each regulatory module are generated from a multivariate normal distribution with marginal means
0 and variances 1. We consider three correlation structures. The first (R1) is an auto-regressive
structure where the correlation between the jth and lth variables is (−0.5)|j−l|. The second (R2) is
a banded structure where the correlation between the jth and lth variables is −0.5 if |j− l| = 1 and
0 otherwise. The third (R3) has a structure where the correlation between the jth and lth variables
is (−1)|j−l|/(|Cs| + |Ds|). Among them, R1 and R2 are “diagonally dominant”, while R3 has all
correlations at the same level. The individual regulators that are not involved in any regulatory
modules are independently generated from the standard normal distribution. As such, regulators in
different modules are independent of each other and also independent of the individual regulators.
(c) Gene expression measurements are generated by G = RΘ + , where the elements of  follow
independent standard normal distributions. (d) Given G, R, and Θ, generate the integrated
information Xs for each module using the top PCs and Z for the individual molecular units. (e)
With Xs, s = 1, · · · , S and Z, consider the continuous response under model (3). Two types of
nonzero coefficient settings are considered, leading to a total of 100 (P1) and 70 (P2) important
main molecular effects and M-E interactions, respectively. These nonzero coefficients are generated
uniformly from (0.5, 0.8) (B1) or (0.8, 1.2) (B2), representing two signal levels, with the “main
effects, interactions” hierarchical structure satisfied. The molecular factors with important effects
include gene expressions and regulators involved in the regulatory modules as well as individual
molecular measurements. Additional information is provided in the Appendix. Random errors ξ
are generated from independent standard normal distributions.
To better appreciate operating characteristics of the proposed module detection procedure,
11
we simulate one dataset under setting Θ1 and correlation structure R1. We present the true
regulation relationships between gene expressions and regulators in Figure 1, together with their
estimated values and identified regulatory modules. We observe that with moderate associations
between small sets of molecular measurements, the estimated Θˆ based on Lasso closely reflects the
true regulation relationships. Furthermore, biclustering is able to properly identify the regulatory
modules based on the estimated regulations.
To be more informative, besides the proposed approach, we also consider the following alter-
natives which have closely related frameworks. Comparing with these alternatives can directly
establish the necessity of the considerations on gene expression-regulator regulations, correlations
within regulatory modules, and hierarchical interactions. Specifically, Alt.1 excludes Step II of inte-
gration and builds the hierarchical interaction model using gene expressions and regulators directly
combined as groups based on the identified regulatory modules. Alt.2 excludes the decomposition
of interaction coefficients in Step III, and so the “main effects, interactions” hierarchical structure
may be violated. Alt.3 builds the hierarchical joint model directly using the original stacked gene
expression and regulator measurements without accounting for the regulations. Alt.4 incorporates
the original stacked gene expression and regulator measurements directly in the interaction model.
It ignores the regulation relationships and interaction hierarchy. For evaluation, we consider the
numbers of true positives (TP) and false positives (FP) for main effects and interactions together.
For each scenario, 200 replicates are simulated. Summary results under settings P1 and P2
are presented in Tables 1 and 2 respectively. We observe that the proposed approach achieves
better or comparable performance in identification accuracy. For example in Table 1 with weak
effects (B1), regulation pattern Θ1, and correlation structure R1, the proposed approach selects
on average 95.94 true positives, compared to 71.90 (Alt.1), 65.20 (Alt.2), 23.15 (Alt.3), and 16.80
(Alt.4). When there are more correlated molecular measurements, the proposed approach remains
superior in identification. For instance in Table 1 with weak effects (B1), regulation pattern Θ1,
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and correlation structure R3, the proposed approach selects on average 99.70 true positives with
8.50 false positives. In comparison, Alt.1, Alt.2, Alt.3, and Alt.4 select fewer true positives and
more false positives with (TP,FP)=(83.68,12.26), (95.90,54.75), (27.30,14.70), and (20.75,136.65),
respectively. With a higher signal level under setting B2, all approaches behave better, while with
more regulation modules under setting Θ2, performance of all approaches decays. Under both
settings, the proposed approach still has advantage. It is observed that Alt.1 generally achieves
the second best identification performance, and under some scenarios it is competitive in true
positive identification compared to the proposed approach, at the cost of larger numbers of false
positives. This is because the integration procedure of the proposed approach that uses PCs for the
joint interaction model can effectively remove collinearity and reduce false discovery. The proposed
approach performs better than Alt.2, suggesting that the hierarchical interaction modeling can lead
to more accurate identification. The superior performance of the proposed approach over Alt.3
and Alt.4 provides a direct support to the integrated analysis strategy that accommodating the
regulations among multidimensional molecular data in interaction analysis substantially improves
identification performance.
4 Data analysis
TCGA is one of the largest data resources with multidimensional profiling. TCGA data have been
analyzed in interaction analysis with one type of molecular measurements as well as integrated
modeling with the main effects of multiple types of molecular measurements. This study is the
first to conduct the integrated M-E interaction analysis. We analyze data on lung adenocarcinoma
(LUAD) and cutaneous melanoma (SKCM). Data are downloaded from TCGA Provisional using
the R package cgdsr.
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4.1 Analysis of LUAD data
The response of interest is the reference value for the pre-bronchodilator forced expiratory volume
in one second in percent (FEV1). It is an important biomarker for lung capacity, with a lower value
suggesting the potentially functional disorder of the lung, and has been shown to be a powerful
marker for future morbidity and mortality (Young et al., 2007). It is continuously distributed and
ranges from 1.95 to 156 with mean 80.58 and standard deviation 23.55. We focus on the primary
tumor samples of the Whites. For environmental risk factors, we consider age, American Joint
Committee on Cancer (AJCC) tumor pathologic stage (Stage), tobacco smoking history indicator
(Smoking), and gender, which have been extensively investigated in the literature. We analyze
mRNA gene expression measurements which were collected using the Illumina HiSeq 2000 RNA
Sequencing Version 2 analysis platform. For regulators, we include CNV measurements that were
collected using the Genome-Wide Human SNP Array 6.0 platform and DNA methylation measure-
ments that were collected using the Illumina Infinium HumanMethylation450 platform. A total
of 18,345 gene expression, 23,321 CNV, and 15,288 methylation measurements are available. In
principle, the proposed approach can be directly applied. However, considering that only a small
number of molecular measurements are potentially associated with the outcome and the analysis
may be unstable with the high dimensionality and small sample size, we conduct a prescreen-
ing. Specifically, we select the top 1,000 molecular measurements with the smallest p-values using
marginal regression. This leads to 164 subjects with 467 gene expression and 533 regulator (316
CNV and 217 methelaytion) measurements for downstream analysis.
The proposed analysis identifies 20 regulatory modules in Step I, and each module on average
contains 11.70 gene expression and 7.35 regulator measurements. The graphical presentation of
the modules is provided in Figure A2 (Appendix), where some overlappings between modules are
observed. In interaction analysis, the proposed approach identifies 62 main molecular effects and
29 M-E interactions, among which 50 main effects and 27 interactions belong to six regulatory
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modules. The identified main effects consist of 41 gene expression, 9 CNV, and 12 methylation
measurements, and the identified interactions consist of 20 with gene expressions and 9 with methy-
lations. Detailed estimation results are presented in Table 3, where a “group” corresponds to a
module or an individual measurement. Literature search suggests that the findings are biologically
sensible. For example, Stage and Smoking are shown to be negatively associated with FEV1, which
has also been suggested in previous studies. Gene AFF3 is identified along with its interactions
with Smoking and gender. A decreased methylation of gene AFF3 in non-small cell lung tumors has
been found as one of the key epigenetic changes associated with lung cancer development. Gene
PWRN1 has been reported to be involved in the process of spermatogenesis, and its expression
level has been shown to be related to tumor size in lung cancer patients. Gene CACNG3 has
been identified as an oncogene from a pan-cancer study with somatic mutation data, suggesting
its potentially important role for lung adenocarcinoma. Gene PRH1 has been identified as one of
the candidate exosomal protein biomarkers for the detection of lung cancer using human saliva and
serum. In addition, published studies have shown that gene CACNG6 is significantly upregulated
in lung squamous cell carcinoma compared to normal lung tissues. Gene PABPC5 has been found
to be hypermethylated among early-stage non-small cell lung cancer patients compared to controls.
Gene MAP4K4 has been demonstrated to be frequently overexpressed in many types of human
cancers, relating to transformation, invasiveness, adhesion, and cell migration. Patients with lung
adenocarcinoma and high MAP4K4 expressions have been found to have a shorter overall survival.
The lower expression levels of gene DRD3 have been found among patients with non-small cell lung
cancer.
We take a closer look at the functional and biological connections of genes involved in each
identified regulatory module. Specifically, the gene ontology (GO) enrichment analysis is conducted
using DAVID version 6.8 (Sherman et al., 2009). It is observed that the identified modules are
biologically meaningful with certain significantly enriched GO terms. For example, in regulatory
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module #1, genes CACNG6 and RYR3 are enriched with calcium channel activity (GO:0005262,
p-value= 0.0042) and calcium ion transport (GO:0006816, p-value=0.0072). Biological studies have
found calcium controls cell death and proliferation that are relevant to tumorigenesis, and up or
down regulations of specific calcium channels and pumps are associated with cancers. As another
example, genes ATP8A2 and DGUOK in regulatory module #20 are enriched with purine nucleoside
triphosphate (GO:0009144, p-value=0.0053) and purine nucleoside metabolic process (GO:0006163,
p-value=0.008), suggesting the functional and biological connections within the identified module.
Analysis is also conducted using the alternative approaches. In Table A1 (Appendix), we provide
the comparison results, including the numbers of identified main effects and interactions, and
numbers of overlapping and RV coefficients between the identifications using different approaches.
The RV coefficient measures the common information of two data matrices. It lies between 0 and
1, and a larger value indicates a higher degree of overlapping. We observe that different approaches
select significantly different sets of main effects and interactions, with moderate overlapping as
measured by the RV coefficients. In practical data analysis, it is difficult to objectively evaluate
identification performance. To provide an indirect support, we evaluate prediction performance
and selection stability. Specifically, for prediction evaluation, we consider the prediction mean
squared error (PMSE) based on 200 random resamplings (9/10 training and 1/10 testing samples).
The proposed approach demonstrates competitive performance with the average PMSE= 1.02,
compared to 1.25 (Alt.1), 1.16 (Alt.2), 1.05 (Alt.3), and 1.02 (Alt.4). We also assess selection
stability using the observed occurrence index (OOI) (Huang et al., 2006). For each identified main
effect (interaction), OOI computes its selection frequency in the 200 resamplings, and a larger value
suggests higher stability. The proposed approach is observed to have much satisfactory stability
with the average OOI value being 0.77, compared to 0.53 (Alt.1), 0.45 (Alt.2), 0.26 (Alt.3), and
0.21 (Alt.4).
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4.2 Analysis of SKCM data
The response of interest is overall survival, which is subject to censoring. We focus on the primary
tumor samples of the Whites. We consider age, AJCC tumor pathologic stage (Stage), gender, and
Clark level at diagnosis (Clark), all of which have been suggested as associated with melanoma in
the literature. A total of 18,925 gene expression, 23,287 CNV, and 15,616 methylation measure-
ments are available. With the same prescreening as in the previous analysis, the data used for
downstream analysis contains 314 gene expression and 686 regulator (397 CNV and 289 methyla-
tion) measurements on 231 subjects, of which 139 died during follow-up. The observed times range
from 2.04 to 357.10 months with median 56.31.
The proposed analysis identifies 17 regulatory modules, which contain on average 7.60 gene
expressions and 6.45 regulators. The graphical presentation is provided in Figure A2 (Appendix).
The AFT model is assumed for modeling survival. A total of 28 main effects and 12 interactions
are selected by the proposed approach, among which 14 main effects belong to one identified
regulatory module and the remaining are related to the individual molecular units. The identified
main effects consist of 15 gene expression and 13 methylation measurements, and the identified
interactions consist of 9 with gene expressions and 3 with methylations. The estimated coefficients
are presented in Table 4. Examining the estimated coefficients suggests that melanoma patients
with higher levels of age, Stage, and Clark have a shorter survival. Findings on the molecular
variables are also sensible. For instance, gene IMP3 has been found to be associated with cell
proliferation and considered as an oncofetal protein-related gene. Its expression level has been used
as a diagnostic and prognostic marker from surgical pathology in malignant melanoma. TBC1D7 is
one of the down-regulated genes that are potentially causal for the induction of loss of proliferative
capacity and terminal differentiation in human melanoma cells. The lack of gene A2M expression
provides a growth advantage to melanoma cells by interfering with effective antigen presentation.
IL24 is a novel tumor suppressor gene with tumor-apoptotic and immune-activating properties,
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and one of several genes that are upregulated during terminal differentiation of melanoma cells.
The high expression level of gene ZDHHC4 has been observed in NRAS mutant melanoma cell
lines. Published studies have also found a statistically significant overexpression of gene BRF2 in
cutaneous melanoma compared to normal skin, and suggested it as a potential marker for patients at
risk for metastasis. Gene RBP2 has been shown to directly regulate gene transcription in a reporter
assay system as a transcriptional regulator with a tumor suppressive potential in melanoma cells.
For the identified module, we further conduct the GO enrichment analysis. It is observed that
the involved genes share common GO terms. For example, genes A2M, ENOX1, and IL24 are
enriched with extracellular space (GO:0005615, p-value=0.0097), for which published studies have
suggested that extracellular vesicles released to extracellular space are correlated with genetic tumor
progression in human cancer.
We conduct analysis using the alternatives and summarize the comparison results in Table A1
(Appendix). Similar patterns as in the previous analysis are observed, where different approaches
have small numbers of overlapping identifications and moderate RV coefficients. We also conduct
the prediction and selection stability evaluation. With the censored survival response, we adopt the
C statistic to measure prediction accuracy (Uno et al., 2011). A larger value of C statistic indicates
better prediction. The proposed approach has an average C statistic 0.60, compared to 0.57 (Alt.1),
0.48 (Alt.2), 0.47 (Alt.3), and 0.59 (Alt.4). In addition, it has superior selection stability with an
average OOI of 0.74, compared to 0.56 (Alt.1), 0.50 (Alt.2), 0.38 (Alt.3), and 0.26 (Alt.4). These
results provide a strong support to the proposed M-E interaction analysis.
5 Discussion
Modeling the outcomes and phenotypes of cancer and other complex diseases is an “old” but still
widely open problem. In this study, we have developed the M-E interaction analysis, which is
the natural next step of the existing literature. In particular, it is built on but advances from
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the existing gene-environment interaction analysis by incorporating multiple types of molecular
measurements (which have overlapping but more importantly independent information in a single
analysis). It also advances from the existing multidimensional molecular data analysis by incor-
porating interactions and respecting the hierarchical structure. The proposed approach has sound
biological and statistical basis. Its working characteristics are carefully examined, and simulation
and data analysis have demonstrated its satisfactory performance.
It remains an open question how to best accommodate multidimensional molecular data in
modeling. The proposed analysis Step I has been motivated by Wang et al. (2012), Zhu et al. (2016),
and several other studies. Similar to the literature, linear modeling and regularized estimation have
been applied for estimating the regulations. Different from the literature, biclustering has been
conducted to identify local regulations, where a small number of co-expressed genes are regulated
by a small number of regulators in a coordinated manner. It advances from Zhu et al. (2016) and
others by relaxing the rank-one constraint. The Step II of dimension reduction can be conducted
by other techniques such as partial least squares, can effectively reduce dimensionality and remove
collinearity, and has been shown as effective in numerical study. There are alternative techniques
for interaction analysis in Step III. We have chosen penalization for the consistency of analysis
framework. It will be of interest to extend by adopting other estimation/selection techniques.
We have used gene expressions and their regulators for description. The proposed approach can
be directly applied to other and potentially more complex data structures, thus enjoying broad
applicability.
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Figure 1: Simulation. Left: true values of regulation under setting Θ1 and R1; Middle: estimated
values; Right: identified regulatory modules.
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Table 1: Summary results for simulation under setting P1 with a total of 100 true positives: mean
(sd) from 200 replicates.
Θ1 Θ2
Approach TP FP TP FP
B1 R1 Proposed 95.94(4.63) 11.39(13.83) 80.06(5.37) 6.31(6.02)
Alt.1 71.90(35.35) 20.45(24.20) 27.06(19.83) 1.94(1.12)
Alt.2 65.20(28.39) 28.75(14.03) 31.69(15.05) 7.94(18.32)
Alt.3 23.15(3.47) 7.45(3.90) 20.35(9.10) 19.85(8.43)
Alt.4 16.80(2.09) 122.20(38.35) 29.85(5.73) 127.40(40.31)
R2 Proposed 97.30(1.75) 5.70(10.99) 80.72(4.64) 20.89(25.90)
Alt.1 86.60(30.13) 13.00(16.06) 47.00(16.82) 6.11(4.92)
Alt.2 85.15(16.11) 39.95(6.87) 33.61(11.44) 19.06(21.78)
Alt.3 23.35(4.18) 7.65(2.89) 21.05(5.77) 25.79(6.27)
Alt.4 16.95(2.86) 126.05(46.47) 16.00(9.56) 71.15(65.52)
R3 Proposed 99.70(0.57) 8.50(14.60) 79.40(3.22) 36.13(38.10)
Alt.1 83.68(27.69) 12.26(18.29) 51.14(25.72) 8.71(11.69)
Alt.2 95.90(8.09) 54.75(12.48) 30.50(14.39) 4.50(7.60)
Alt.3 27.30(1.63) 14.70(17.41) 20.21(7.79) 22.11(8.46)
Alt.4 20.75(2.65) 136.65(37.06) 20.00(8.55) 103.05(63.77)
B2 R1 Proposed 99.80(0.41) 14.25(18.95) 83.90(4.43) 12.60(10.56)
Alt.1 99.80(0.41) 57.80(22.75) 32.00(23.43) 14.35(13.92)
Alt.2 85.80(14.06) 55.55(27.20) 34.75(13.98) 18.25(9.48)
Alt.3 27.17(2.46) 5.28(1.02) 27.15(8.67) 35.15(11.45)
Alt.4 21.45(2.98) 142.05(31.31) 30.30(10.98) 110.10(66.72)
R2 Proposed 99.82(0.39) 4.12(14.69) 77.88(3.67) 20.81(12.93)
Alt.1 90.80 (27.98) 38.65(21.69) 42.69(22.46) 12.06(8.73)
Alt.2 77.85(19.63) 47.05(16.62) 21.75(19.49) 19.05(22.55)
Alt.3 27.37(2.29) 7.79(3.31) 17.45(5.84) 18.95(11.87)
Alt.4 19.60(2.19) 135.35(36.02) 14.95(9.74) 52.40(47.98)
R3 Proposed 99.35(0.67) 12.05(17.72) 77.77(2.95) 9.85(6.67)
Alt.1 96.45(13.77) 50.45(17.38) 35.65(19.45) 21.95(13.06)
Alt.2 86.45(12.17) 46.45(11.91) 16.50(16.99) 10.00(13.13)
Alt.3 28.88(3.14) 7.71(2.52) 14.35(4.89) 16.35(7.19)
Alt.4 21.25(2.71) 140.65(30.84) 14.95(10.79) 65.15(62.45)
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Table 2: Summary results for simulation under setting P2 with a total of 70 true positives: mean
(sd) from 200 replicates.
Θ1 Θ2
Approach TP FP TP FP
B1 R1 Proposed 68.85(0.88) 0.40(0.50) 67.30(3.26) 2.30(5.65)
Alt.1 63.30(15.69) 34.80(23.26) 33.95(20.68) 6.68(10.37)
Alt.2 65.25(4.27) 31.85(8.55) 52.15(10.98) 38.30(36.79)
Alt.3 22.25(4.46) 7.85(4.49) 20.95(4.32) 23.85(9.28)
Alt.4 15.30(2.75) 129.45(42.29) 28.10(4.10) 127.65(43.63)
R3 Proposed 57.15(18.43) 10.50(6.36) 53.90(12.49) 2.65(2.21)
Alt.1 42.55(28.65) 18.00(25.46) 38.25(15.21) 4.40(8.18)
Alt.2 42.50(21.19) 24.05(14.57) 28.00(17.26) 3.70(6.14)
Alt.3 24.50(2.50) 10.90(8.42) 18.00(11.31) 23.00(24.04)
Alt.4 14.30(1.95) 107.05(30.44) 16.95(5.31) 83.85(51.99)
R3 Proposed 67.15(6.71) 1.40(3.98) 51.90(13.63) 2.55(2.74)
Alt.1 61.00(19.74) 27.80(17.56) 34.25(6.54) 8.10(14.49)
Alt.2 65.35(5.05) 36.35(11.94) 44.45(15.43) 47.00(43.04)
Alt.3 22.75(2.90) 9.95(7.49) 15.75(4.88) 18.85(12.33)
Alt.4 15.40(2.26) 117.65(30.91) 19.20(5.69) 105.85(61.27)
B2 R2 Proposed 69.75(0.55) 1.70(6.67) 67.05(5.88) 10.50(11.00)
Alt.1 69.75(0.44) 32.30(11.68) 65.40(7.38) 28.65(30.47)
Alt.2 66.40(5.23) 38.15(30.67) 46.00(12.02) 2.30(5.25)
Alt.3 25.79(5.54) 11.05(17.48) 20.95(4.32) 23.85(9.28)
Alt.4 16.65(2.21) 136.00(36.41) 36.25(4.27) 150.50(45.17)
R2 Proposed 67.15(11.35) 1.15(3.77) 57.10(11.11) 4.55(4.08)
Alt.1 69.80(0.52) 33.70(12.69) 41.85(15.79) 16.35(9.42)
Alt.2 58.15(9.91) 36.55(11.76) 43.55(15.74) 11.50(13.61)
Alt.3 26.85(2.89) 6.85(2.13) 18.00(11.31) 23.00(24.04)
Alt.4 17.50(2.65) 148.40(45.18) 18.90(6.21) 91.40(53.36)
R3 Proposed 69.85(0.37) 2.80(7.25) 56.77(8.12) 3.69(6.32)
Alt.1 68.90(4.46) 32.95(9.29) 39.35(12.57) 19.35(18.79)
Alt.2 66.35(6.67) 35.45(7.99) 50.05(11.98) 7.15(14.18)
Alt.3 26.70(3.37) 7.40(3.42) 15.75(4.88) 18.85(12.33)
Alt.4 16.75(1.97) 133.65(32.08) 16.20(6.05) 63.40(43.57)
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Table 3: Analysis of the LUAD data using the proposed method: identified main effects and
interactions.
Group Type Gene Main Age Stage Smoking Gender
0.010 -0.031 -0.201 -0.067
1 GE VIT 0.006
1 GE PRH1 0.007
1 GE NOXRED1 0.006
1 GE RYR3 0.007
1 GE SERPINB11 0.007
1 GE ZNF273 0.004
1 GE WRAP53 0.003
1 GE SNORA7B 0.006
1 GE GUCY2F 0.007
1 GE STATH 0.007
1 GE CACNG6 0.007
1 DM WIPI2 -0.005
3 GE LINC00922 -0.059 0.009 0.001 0.004
3 GE NDP -0.059 0.008 0.001 0.004
3 GE TNMD -0.055 0.008 0.001 0.004
3 GE IBSP -0.055 0.008 0.001 0.004
3 GE PWRN1 -0.053 0.008 0.001 0.004
3 GE CACNG3 -0.053 0.008 0.001 0.004
3 DM MIS18A -0.045 0.007 0.001 0.003
3 DM RRP1 -0.036 0.005 0.001 0.002
3 DM ZDHHC2 -0.044 0.006 0.001 0.003
9 GE ZXDA -0.014
9 GE EXOSC8 0.022
9 GE EPSTI1 0.020
9 GE UGT2B4 -0.012
9 CNV SLC22A10 0.009
9 CNV PABPC5 0.018
9 DM ATP8A2 0.010
9 DM DHX32 0.013
15 GE KL -0.016
15 CNV MAP4K4 -0.013
15 CNV KCMF1 -0.016
15 DM SATB2 -0.013
Continued on the next page
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Table 3: Continued from the previous page.
Group Type Gene Main Age Stage Smoking Gender
16 GE HIST1H2AA -0.009
16 GE KCNIP3 -0.008
16 GE LRRTM3 -0.011
16 GE DCLRE1A -0.012
16 GE PPP1R3D -0.007
16 GE NHLRC2 -0.009
16 GE NPAP1 -0.010
16 CNV MAP4K4 -0.011
20 GE FTSJ1 0.013
20 GE DGUOK 0.012
20 GE SESN3 -0.008
20 GE CAPZB 0.009
20 CNV PABPC5 0.005
20 CNV MRGPRD 0.008
20 DM IL17D 0.008
20 DM ATP8A2 0.006
20 DM DHX32 0.004
21 GE AFF3 -0.106 0.147 -0.013
27 GE SGPP2 -0.009
47 GE FNIP2 -0.027
50 GE C11orf65 0.005
68 GE DRD3 0.012
102 GE DPRX 0.026
124 GE PRIMA1 -0.016
178 GE FAM217B -0.013
304 CNV AK4 0.014
319 CNV MIR582 -0.024
423 DM HOXA1 -0.027
520 DM SDE2 0.014
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Table 4: Analysis of the SKCM data using the proposed method: identified main effects and
interactions.
Group Type Gene Main Age Stage Gender Clark
-0.176 -0.099 0.150 -0.042
14 GE MYCNOS 0.003
14 GE MRGPRX3 0.004
14 GE MFSD6L 0.005
14 GE IMP3 0.005
14 GE TBC1D7 0.003
14 GE A2M 0.004
14 GE NEURL2 0.005
14 GE IL24 0.004
14 DM MAU2 0.004
14 DM ZDHHC4 0.004
14 DM ENOX1 0.002
14 DM PTPN12 0.005
14 DM BRF2 0.002
14 DM SYT6 0.002
70 GE DSTYK -0.054 0.123 -0.164
71 GE GLDN 0.044 -0.058 0.012
82 GE RBP2 -0.029 -0.026
124 GE SATB2 -0.057 -0.032 0.034
153 GE RPL36AL 0.003
204 GE RNPS1 -0.057 0.112 0.084
214 GE ARL6IP1 -0.014
573 DM DPY19L3 0.006
640 DM RABEP1 -0.080 -0.071 0.010
647 DM SLU7 -0.004
654 DM KLHL31 -0.023
696 DM GLMP -0.016
714 DM BNIP1 -0.025
759 DM MS4A15 0.055 -0.045
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Appendix
Analysis flowchart
Figure A1: Flowchart of the proposed M-E interaction analysis.
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Computational algorithms
Algorithm 1 Identifying regulatory module
1. Estimate Θˆ with objective function (1) using R package glmnet.
2. Initialize s = 0 U (s) as the normalized matrix of Θˆ, where U (s) denotes the remaining
regulation relationships at iteration s.
3. s = s + 1. Apply the sparse 2-means clustering to U (s) based on objective function (2),
and obtain two clusters Cs and C¯s for regulators as well as the weight vector ws for gene
expressions, using R package sparcl.
4. Fix Cs and C¯s, and permute the rows of U (s) to calculate weight w∗s,j = bj/
√∑
j′ b
2
j′ with
bj =
(
1
q
∑q
l=1
∑q
l′=1 dl,l′,j − 1q1
∑
l,l′∈Cs dl,l′,j − 1q2
∑
l,l′∈C¯s dl,l′,j
)
, under the null hypothesis of
no clusters.
5. Repeat Step 4 B times, and then compute w0s,(j) =
∑B
k=1w
∗
s,(j),k/B with w
∗
s,(j),k being the
jth order statistic of the weights at iteration k of Step 4.
6. Conduct a two-sample Kolmogorov-Smirnov test to compare ws and w
0
s .
7. If the test at Step 6 rejects the null hypothesis at significance level 0.05, then j∗ gene ex-
pressions with the largest weights are selected, where j∗ = arg maxj
(
w(p−j+1) − w0(p−j+1)
)
−(
w(p−j) − w0(p−j)
)
. Denote the corresponding index set as Ds. Update U (s+1) by excluding
the information of the identified module {Cs,Ds} as
U
(s+1)
lj =
{
U
(s)
lj − (U¯ (s)Cs,j − U¯
(s)
C¯s,j), if l ∈ Cs and j ∈ Ds
U
(s)
lj , otherwise,
where U¯
(s)
Cs,j =
1
q1
∑
i∈Cs U
(s)
ij and U¯
(s)
C¯s,j =
1
q2
∑
i∈C¯s U
(s)
ij .
8. Repeat Steps 3-7 until the test at Step 6 fails to reject the null hypothesis, and return the
final regulatory modules {C1,D1} , · · · , {CS ,DS} with S + 1 being the termination iteration.
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Algorithm 2 M-E interaction analysis with integrated molecular data
1. Initialize t = 0, Φ(0) = 0, and res(0) = Y , where Φ(t) and res(t) denote the estimates of Φ
and residual res at iteration t.
2. Update t = t+ 1. Optimize Q(Φ) by cycling through α, βs, γ, ηsm and τm.
(a) Update α with the least squared solution. Let Y˜ = res(t−1) + Eα(t−1), then α(t) =
(E′E)−1E′Y˜ . Update res(t−1) = Y˜ −Eα(t).
(b) For s = 1, . . . , S, update βs sequentially. Let Y˜ = res
(t−1) +Xsβ
(t−1)
s +
∑M
m=1(E
′
m 
X ′s)′
(
β
(t−1)
s ∗ η(t−1)sm
)
and W˜s = (W˜s1, . . . , W˜s,ps) = Xs +
∑
m(E
′
m X ′s)′ 
(
η
(t−1)
sm
)′
.
Then, if ||W˜ ′sY˜ ||2 < λ1
√
ps, update β
(t)
s = 0; Otherwise, update β
(t)
sj = arg min
βsj
1
2 ||Y˜ −∑
j′ 6=j W˜sj′ βˆ
(t)
sj′ − W˜sjβsj ||22 + λ1
√
ps||βsj ||2, for j = 1, . . . , ps, using the R function
optimize. Update res(t−1) = Y˜ − W˜sβ(t)s .
(c) For d = 1, . . . , pz, update γd sequentially. Let Y˜ = res
(t−1) + Zdγ
(t−1)
d +
M∑
m=1
(Em ∗ Zd)
(
γ
(t−1)
d τ
(t−1)
md
)
and W˜d = Zd +
∑
m(Em ∗ Zd)τ (t−1)md , update γ(t)d =
ST
(
(W˜ ′dW˜d)
−1W˜ ′dY˜ , (W˜
′
dW˜ )
−1λ2
)
, where ST (a, b) = sign(a)(|a| − b)+ is the soft-
thresholding operator. Update res(t−1) = Y˜ − W˜dγ(t)d .
(d) For m = 1, . . . ,M and s ∈
{
s : β
(t)
s 6= 0, s = 1, · · · , S
}
, update ηsm sequentially. Let
Y˜ = res(t−1) + (E′m  X ′s)′
(
β
(t−1)
s ∗ η(t−1)sm
)
and W˜sm = (W˜sm,1, . . . , W˜sm,ps) =
(E′m  X ′s)′ 
(
β
(t−1)
s
)′
. Then, if ||W˜ ′msY˜ || < λ1
√
ps, update η
(t)
sm = 0; otherwise,
update η
(t)
sm,j = arg min
ηsm,j
1
2 ||Y˜ −
∑
j′ 6=j W˜sm,j′η
(t)
sm,j′ − W˜sm,jηsm,j ||22 + λ1
√
ps||ηmsj ||2 for
j = 1, . . . , ps. Update res
(t−1) = Y˜ − W˜smη(t)sm.
(e) For m = 1, . . . ,M and d ∈
{
d : γ
(t)
d 6= 0, d = 1, . . . , pz
}
, update τˆmd sequentially. Let
Y˜ = res(t−1) + (Em ∗ Zd)
(
γ
(t−1)
d τ
(t−1)
md
)
and W˜md = (E
′
m  Z ′d)′γ(t−1)d , then τ (t)md =
ST
(
(W˜ ′mdW˜md)
−1W˜ ′mdY˜ , (W˜
′
mdW˜md)
−1λ2
)
. Update res(t) = Y˜ − W˜mdτ (t)md.
3. Repeat Step 2 until convergence. In our numerical study, convergence is concluded if
|Q(Φˆ(t−1))−Q(Φˆ(t))|
|Q(Φˆ(t−1))| < 10
−4.
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Detailed simulation settings
In Step (e) of simulation, the important main molecular effects and M-E interactions are set as
follows.
• P1 with a total of 100 important effects under the regulation pattern Θ1: The important
main molecular effects consist of 15 gene expressions and 20 regulators, among which 30 are
involved in one regulatory module and the remaining five are molecular units with individual
effects. There are 25 interactions with gene expressions and 40 interactions with regulators,
relating to one regulatory module and five individual molecular units.
• P1 with a total of 100 important effects under the regulation pattern Θ2: The important
main molecular effects consist of 25 gene expressions and 21 regulators, among which 33 are
involved in two regulatory modules and the remaining 13 are molecular units with individual
effects. There are 36 interactions with gene expressions and 18 interactions with regulators,
relating to one regulatory module and nine individual molecular units.
• P2 with a total of 70 important effects under the regulation pattern Θ1: The important
main molecular effects consist of 15 gene expressions and 20 regulators, among which 30 are
involved in one regulatory module and the remaining five are molecular units with individual
effects. There are 15 interactions with gene expressions and 20 interactions with regulators,
relating to one regulatory module and five individual molecular units.
• P2 with a total of 70 important effects under the regulation pattern Θ2: The important
main molecular effects consist of 17 gene expressions and 21 regulators, among which 33 are
involved in two regulatory modules and the remaining five are molecular units with individual
effects. There are 20 interactions with gene expressions and 12 interactions with regulators,
relating to one regulatory module and four individual molecular units.
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Additional data analysis results
Identified regulatory modules in LUAD
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GEs
R
eg
ul
at
or
s
1 100 200 314
68
6
60
0
50
0
40
0
30
0
20
0
10
0
1
−1.5
−1.0
−0.5
0.0
0.5
1.0
1.5
2.0
Figure A2: Data analysis: identified regulatory modules.
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Table A1: Data analysis: numbers of overlapping main molecular effects and M-E interactions
(RV-coefficients) identified by different methods.
LUAD Proposed Alt.1 Alt.2 Alt.3 Alt.4
Proposed 62(1) 7(0.32) 57(0.65) 4(0.24) 9(0.3)
Alt.1 90(1) 3(0.31) 2(0.08) 33(0.58)
Main effects Alt.2 140(1) 6(0.24) 11(0.36)
Alt.3 11(1) 2(0.08)
Alt.4 66(1)
Proposed Alt.1 Alt.2 Alt.3 Alt.4
Proposed 35(1) 0(0) 4(0.10) 1(0.11) 3(0.08)
Alt.1 8(1) 1(0.03) 2(0.28) 1(0.12)
Interactions Alt.2 30(1) 1(0.1) 1(0.07)
Alt.3 11(1) 6(0.27)
Alt.4 122(1)
SKCM Proposed Alt.1 Alt.2 Alt.3 Alt.4
Proposed 28(1) 9(0.47) 18(0.62) 9(0.52) 4(0.39)
Alt.1 22(1) 7(0.39) 12(0.72) 6(0.53)
Main effects Alt.2 35(1) 7(0.39) 4(0.37)
Alt.3 13(1) 4(0.51)
Alt.4 10(1)
Proposed Alt.1 Alt.2 Alt.3 Alt.4
Proposed 12(1) 2(0.36) 0(0.00) 2(0.32) 1(0.11)
Alt.1 4(1) 0(0.01) 3(0.66) 1(0.19)
Interactions Alt.2 2(1) 0(0.00) 0(0.01)
Alt.3 14(1) 1(0.20)
Alt.4 8(1)
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